Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (718)	10/12/1999 10:45:00 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 4474

I got a slow fill at Schwab at the open, 15/16. This is a mega-surprise to me, 40 million. It positions the company for product-by-product licensing. Royalty rates will be low, but the targeted indications are huge hits. We have a going company.

To: Biomaven who wrote (718)	10/12/1999 10:54:00 AM
From: LLCF	Read Replies (1) \| Respond to of 4474

<I bought some this morning at around $1. The floorless will soon be behind us - only question is how many million shares they will end up with.> This is what we needed... the convert's will have to exercise a slug on this move... of course they will be in the market shorting today IMO, but if it get's rid of it, that's great... expensive as it may be [the company will have to sell stock @ 5/8 tonight... OUCH]. < restrict a holder from converting shares of Series C Preferred Stock to the extent that such conversion would result in any holder holding more than 4.99% of the then issued and outstanding shares of common stock> This is very important indeed IMO... it keeps them from stealing the company as I has speculated in any event... isn't 5% the threthold for filing with the SEC?? DAK